ACELYRIN, INC Correlations
SLRN Stock | USD 2.75 0.06 2.23% |
The current 90-days correlation between ACELYRIN, INC Common and Park Electrochemical is -0.06 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACELYRIN, INC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACELYRIN, INC Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
ACELYRIN, INC Correlation With Market
Good diversification
The correlation between ACELYRIN, INC Common and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and DJI in the same portfolio, assuming nothing else is changed.
ACELYRIN, |
Moving together with ACELYRIN, Stock
Moving against ACELYRIN, Stock
0.69 | ZVSA | ZyVersa Therapeutics | PairCorr |
0.6 | KRON | Kronos Bio Earnings Call This Week | PairCorr |
0.59 | VIGL | Vigil Neuroscience | PairCorr |
0.58 | NBY | NovaBay Pharmaceuticals | PairCorr |
0.52 | ETON | Eton Pharmaceuticals | PairCorr |
0.47 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.41 | MOLN | Molecular Partners | PairCorr |
0.32 | NKTX | Nkarta Inc Earnings Call This Week | PairCorr |
0.6 | ELMD | Electromed | PairCorr |
0.59 | COLL | Collegium Pharmaceutical | PairCorr |
0.55 | RMD | ResMed Inc | PairCorr |
0.52 | BDX | Becton Dickinson | PairCorr |
0.49 | SUPN | Supernus Pharmaceuticals | PairCorr |
0.47 | GKOS | Glaukos Corp | PairCorr |
0.44 | COO | Cooper Companies, | PairCorr |
0.43 | RYTM | Rhythm Pharmaceuticals | PairCorr |
0.41 | INFU | InfuSystems Holdings | PairCorr |
0.39 | DAWN | Day One Biopharmaceu Downward Rally | PairCorr |
0.36 | SMMT | Summit Therapeutics PLC | PairCorr |
Related Correlations Analysis
-0.4 | 0.04 | -0.36 | 0.0 | 0.51 | 0.52 | FQVTF | ||
-0.4 | 0.5 | 0.46 | 0.0 | -0.75 | -0.55 | PKE | ||
0.04 | 0.5 | 0.16 | 0.0 | -0.36 | 0.01 | COCO | ||
-0.36 | 0.46 | 0.16 | 0.0 | -0.48 | -0.47 | SHIM | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | LBEV | ||
0.51 | -0.75 | -0.36 | -0.48 | 0.0 | 0.76 | BUD | ||
0.52 | -0.55 | 0.01 | -0.47 | 0.0 | 0.76 | CTYMF | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ACELYRIN, Stock performing well and ACELYRIN, INC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ACELYRIN, INC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
FQVTF | 2.06 | 0.14 | 0.10 | 15.27 | 2.03 | 4.40 | 28.04 | |||
PKE | 1.32 | (0.10) | 0.00 | (0.23) | 0.00 | 2.20 | 7.97 | |||
COCO | 1.67 | 0.00 | 0.00 | (0.11) | 0.00 | 4.21 | 19.52 | |||
SHIM | 3.70 | (0.68) | 0.00 | (0.97) | 0.00 | 7.96 | 25.88 | |||
LBEV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
BUD | 1.07 | 0.30 | 0.22 | 2.14 | 1.34 | 2.29 | 9.04 | |||
CTYMF | 3.31 | 0.94 | 0.19 | (303.07) | 2.92 | 9.00 | 27.62 |
ACELYRIN, INC Corporate Management
Patricia Turney | Chief Officer | Profile | |
Kenneth Lock | Chief Officer | Profile | |
Gilbert JD | Principal Officer | Profile | |
Shephard MD | Senior Development | Profile | |
Kelly Chow | Chief Officer | Profile | |
Ron Oyston | Chief Officer | Profile |